Key result
Cryoballoon pulmonary vein isolation and radiofrequency ablation demonstrated comparable optimal clinical success rates in patients with atrial fibrillation.
Why the study?
The study was conducted to estimate the clinical success of cryoballoon pulmonary vein isolation.
Does cryoballoon ablation improve clinical success compared to radiofrequency ablation in patients with symptomatic atrial fibrillation resistant to antiarrhythmic therapy?
RCT (n=230)
Open-label
Randomized
No
Does cryoballoon ablation improve clinical success compared to radiofrequency ablation in patients with symptomatic atrial fibrillation resistant to antiarrhythmic therapy?
Answers are grounded in this paper and cite their sources.
Cryoballoon and radiofrequency ablation have comparable clinical success rates for pulmonary vein isolation in patients with atrial fibrillation, with cryoablation showing significant improvements in quality of life.
Aim . To estimate the clinical success of cryoballoon pulmonary vein isolation (PVI). Methods. 230 patients (males: 49.6%, mean age 57 (53; 62) with symptomatic paroxysmal and persistent atrial fibrillation (AF) resistant to antiarrhythmic therapy were included in a single-center prospective study. The patients were randomized into 2 groups to undergo either cryoballoon ablation (n = 122) or radiofrequency (RF) (n = 108) ablation. Both groups were comparable in baseline parameters. The follow-up period was 12 months. Clinical outcomes were estimated with the use of a three-stage scale. The rates of cardiovascular rehospitalizations, direct-current cardioversions and repeated ablations during were estimated within the follow-up. The quality of life (QoL) in the cryoablation group was measured using the AFEQT scale. Results. 77% (n = 94) of patients in the cryoballoon ablation group and 71.3% (n = 77) of patients in the RF group (р = 0.71) demonstrated reported the optimal clinical effects. Both groups, cryo ablation and RF ablation, had similar rates of cardiovascular hospitalizations (23.8 vs 28.7%, OR 0.8, 95% CI 0.4–1.4; р = 0.39), direct-current cardioversions (12.3 vs 17.6%, OR 0.7, 95% CI 0.3–1.4; р = 0.26) and repeated ablations (9.8–11.1%, OR 0.9, 95% CI 0.4–2.0; р = 0.75). The patients treated with cryoballoon as opposed to RF ablation had significantly more successful usage of “pill-in-pocket” strategy – 14.8 vs 6.5% (OR 2.5, 95% CI 1.01–6.2; р = 0.04). Significant improvements of the QoL parameters with strong size effect have been found in the cryoablation group, i.e. global score (GS) increased by 8.9±6.9 (95% CI 6.6–10.1; dCohen 1.2; р<0.001), symptoms (S) – by 8.3±7.9 (95% CI 4.2–8.8; dCohen 1.5; р<0.001), daily activities (DA) – by 10.0±6.9 (95% CI = 6.4–10.6; dCohen 0.9; р<0.001), treatment concerns (TC) – by 5.5±6.0 (95% CI 6.3–9.2; dCohen 1.2; р<0.001) and treatment satisfaction (TS) – by 5.5±6.0 (95% CI 5.4–9.8; dCohen 0.9; р<0.001). Conclusion. The both catheter-based technologies had comparable clinical success. Cryoablation was characterized by improvement in all QoL parameters based on the AFEQT score.
No takes yet. Share an insight, caveat, or question.
Chichkova et al. (2019) conducted an RCT in Atrial fibrillation (n=230). Cryoballoon pulmonary vein isolation vs. Radiofrequency ablation was evaluated on Optimal clinical effect (p=0.71). Cryoballoon pulmonary vein isolation and radiofrequency ablation demonstrated comparable optimal clinical success rates in patients with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: